Skip to content

Insider · CIK 0001008643

David Green

director

Files at HRGN (Harvard Apparatus Regenerative Technology, Inc.). First filing -, latest -.

David Green files SEC Form 4 as director at HRGN (Harvard Apparatus Regenerative Technology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; David Green has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 27, 2025HRGN
Harvard Apparatus Regenerative Technology, Inc.
AGrant or award
Stock Option (right to buy)derivative
+18,590$0.00$018,590Jul 1, 2025
Jun 27, 2025HRGN
Harvard Apparatus Regenerative Technology, Inc.
AGrant or award
Stock Option (right to buy)derivative
+15,227$0.00$015,227Jul 1, 2025

Questions about David Green

Answered from the filings on this page, as of the latest one.

Is David Green buying or selling?

David Green has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did David Green's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Green has 0.

Where does David Green file Form 4?

David Green has filed Form 4 at HRGN (Harvard Apparatus Regenerative Technology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.